domingo, 4 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 25, 2026

Tech stocks today: Nvidia stock rises as guidance signals AI boom alive and well

View original at finance.yahoo.com
Tech stocks today: Nvidia stock rises as guidance signals AI boom alive and well Nvidia (NVDA), the world's largest company by market capitalization, reported fourth quarter results after the closing bell on Wednesday in a highly anticipated release amid growing concerns about how big bets on AI will pay off…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • We feel generally pretty favorable in terms of Nvidia for the quarter and even for the guidance. I think the real question mark is sentiment.

    80% confidence
  • Anthropic/OpenAI do not have 20-year enterprise distribution networks, CIO relationships, or embedded vertical workflows. CRM, NOW, and MSFT sit at the application layer where business logic lives. The model layer will commoditize faster than the workflow layer

    80% confidence
  • While these use cases are impressive, the reality is that these new AI tools will not rip and replace existing software ecosystems and data environments with these AI tools only as useful as the data it can reach

    80% confidence
  • AI agents and autonomous workflows dramatically increase the attack surface — more APIs, more machine identities, more lateral movement risk, and more cloud-native workloads. AI doesn't reduce the need for endpoint, identity, cloud, and SOC automation, it multiplies it

    80% confidence
  • For the fourth quarter, hyperscaler revenue increased and remained our largest customer category at slightly over 50% of Data Center revenue, while growth was led by the rest of our Data Center customers as revenue diversified

    80% confidence
  • The real debate is what growth looks like in 2027 and 2028

    80% confidence
  • Nvidia has not yet sold any of its H200 chips to Chinese customers

    80% confidence
  • Data Center revenue for the fourth quarter was a record $62.3 billion, up 75% from a year ago and up 22% sequentially, driven by major platform shifts – accelerated computing and AI

    80% confidence
  • Nvidia's stock has been right around with the market for three to six months. To us, that suggests investors really don't have massive expectations built up for the quarter.

    80% confidence
  • The market is conflating foundation model capability with full enterprise software replacement and the fear that generative AI will 'rewrite legacy systems overnight' ignores enterprise reality

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,340 documentos-fonte arquivados
Consulte estes dados → isubstrate.com